NuggMD Launches Its Leading Marijuana Telemedicine Service in Delaware


Ryan Allway

October 2nd, 2023

News, Top News, Top Story


NuggMD’s video telehealth platform connects state-licensed medical marijuana doctors to their patients for affordable, safe online evaluations.

 

 

Wilmington, DE | October 02, 2023 –  NuggMD, the nation’s leading medical marijuana telemedicine platform, is launching its service in Delaware for just $99 for a limited time. Since its founding in 2015, NuggMD has connected over 1,000,000 patients to their medical marijuana physicians.

It’s legal to possess and use cannabis in the state, but adult-use sales aren’t expected to begin until November 2024 at the soonest, and more likely later in 2025.

Medical patients in the state opposed the option to allow the existing, tightly-regulated medical dispensaries to begin adult-use sales earlier due to fears that there wouldn’t be enough cannabis to serve both medical and recreational needs, which would cause a spike in prices.

“It’s understandable that patients would be worried about a spike in prices with an uncontrolled launch of recreational sales,” says Alex Milligan, CMO and co-founder of NuggMD. “It has happened in other states, leaving patients in a bad situation. But the current situation brings about other safety concerns. State residents can possess cannabis and use it legally, but can’t buy safe, tested weed unless they’re patients.”

“I don’t suggest you turn to the black market while waiting for dispensaries to open,” says Kam Babazade, COO and co-founder of NuggMD. “Recent tests on black market products on the East Coast have shown contaminants, synthetic cannabinoids, and major discrepancies in potency. This is something you especially want to avoid if you have significant medical issues.”

“We have diverted over a million patients from the black market now,” says Collin Mann, NuggMD co-founder and CEO. “Delaware was wise to allow telemedicine so even more patients can be turned toward the legal, tested, and safe products in the state’s existing dispensaries.”

NuggMD’s platform is available from 8 am to 10 pm seven days a week. No appointment is needed, and patients who don’t qualify for their state’s medical cannabis program won’t be charged for their evaluation.

 

About NuggMD

 

NuggMD is the nation’s leading medical marijuana technology platform, serving patients in California, Connecticut, Delaware, Georgia, Illinois, Iowa, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Delaware, Nevada, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Texas, Vermont, Virginia, Washington, and West Virginia. They’ve connected over 1,000,000 patients face-to-face with their new medical marijuana doctors via their state-of-the-art telemedicine platform. They believe every human being has the right to explore the benefits of medical cannabis and are fully committed to helping each patient explore every option in their journey to wellness. For further information, visit NuggMD.com/Delaware.

 

Contact Details

 

Andrew Graham

+1 646-385-0189

andrew.g@getnugg.com

Company Website

 

http://www.nuggmd.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading